{
    "Trade/Device Name(s)": [
        "epoc Blood Urea Nitrogen Test",
        "epoc Total Carbon Dioxide Test"
    ],
    "Submitter Information": "Epocal Inc.",
    "510(k) Number": "K171247",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053110"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CDS",
        "JFL"
    ],
    "Summary Letter Date": "January 17, 2018",
    "Summary Letter Received Date": "December 13, 2017",
    "Submission Date": "December 11, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1770",
        "21 CFR 862.1160"
    ],
    "Regulation Name(s)": [
        "Urea nitrogen test system",
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Blood Urea Nitrogen (BUN)",
        "Total Carbon Dioxide (TCO2)"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood",
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "Unanticoagulated tube",
        "epoc Care-Fill Capillary Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "epoc Blood Analysis System",
        "epoc Host",
        "epoc Reader",
        "epoc BGEM Test Card"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical multi-sensor array"
    ],
    "Methodologies": [
        "Quantitative testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Instrument",
        "Test Card",
        "System",
        "Accessory",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for epoc Blood Urea Nitrogen and Total Carbon Dioxide Tests on the epoc Blood Analysis System for quantitative measurement in whole blood.",
    "Indications for Use Summary": "Quantitative measurement of blood urea nitrogen and total carbon dioxide in heparinized or unanticoagulated arterial, venous, or capillary whole blood to aid in the diagnosis and treatment of renal, metabolic, and acid-base disorders, for use in laboratory or point-of-care settings by trained professionals.",
    "fda_folder": "Clinical Chemistry"
}